Question 1

What is the PE ratio of BMY?

Accepted Answer

The trailing twelve-month PE ratio of BMY reflects how much investors pay per dollar of Bristol-Myers Squibb Company's earnings. This metric is most useful when compared to Drug Manufacturers - General peers and the company's own historical range.

Question 2

Is BMY overvalued based on PE ratio?

Accepted Answer

Whether BMY is overvalued depends on comparing its PE ratio to Drug Manufacturers - General peers, historical averages, and growth expectations. A PE above the sector average may indicate overvaluation, but high-growth companies often command premium multiples. Consider pairing PE analysis with a DCF model for a more complete picture.

Question 3

How do I value BMY stock using PE ratio?

Accepted Answer

To value Bristol-Myers Squibb Company using PE: (1) Compare the current PE against the Drug Manufacturers - General median to assess relative pricing, (2) check the PEG ratio to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.

Question 4

What is the PEG ratio of BMY?

Accepted Answer

The PEG ratio divides the PE ratio by the expected earnings growth rate, providing a growth-adjusted valuation metric. A PEG below 1.0 may indicate undervaluation relative to growth, while above 2.0 may suggest overvaluation. PEG is most reliable for companies with stable, predictable earnings growth.

Question 5

Should I use PE ratio or DCF for BMY stock valuation?

Accepted Answer

PE ratio gives a quick relative read — how BMY is priced versus Drug Manufacturers - General peers. DCF provides an absolute value based on projected free cash flows. For BMY, with a strong ROE of 39.3%, both methods are worth using — PE for a market-relative check, DCF to stress-test whether fundamentals justify the price. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.

Bristol-Myers Squibb Company (BMY) PE 估值

使用 PE 市盈率计算 BMY 公允价值

公司简介

财务指标 — BMY PE 估值数据

常见问题

BMY 的市盈率是多少？

基于市盈率，BMY 被高估了吗？

如何使用市盈率对 BMY 进行估值？

BMY 的 PEG 比率是多少？

对 BMY 应该使用 PE 还是 DCF 估值？

了解更多

相关 PE 估值